Table 1.
BPH | Cancer | |
---|---|---|
N = 114 | N = 105 | |
Median Age (range, y) | 60 (30-86) | 60 (41-79) |
Race | ||
White | 73 (64) | 72 (69) |
African American | 30 (26) | 17 (16) |
Other | 11 (10) | 16 (15) |
Median Serum PSA (ng/ml) | 0.9+1.8 | 5.7 ± 5.1 |
Clinical Stage | ||
T1c | n/a | 74 (70%) |
T2a | n/a | 26 (25%) |
T2b | n/a | 1 (1%) |
T2c | n/a | 2 (2%) |
T3a/b | n/a | 1 (1%) |
T2aNxM1 | n/a | 1 (1%) |
Gleason Score | ||
6 | n/a | 68 (65%) |
7 | n/a | 23 (22%) |
>7 | n/a | 14 (13%) |